Study to Compare Different Formulations of AZD3355
NCT00688402
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG:
AZD3355
Sponsor
AstraZeneca